©2017 by Dr Amanda Saracino Medical Dermatologist London.

Amanda small Picture.jpg

DR AMANDA SARACINO

MBBS  BMedSc CESR FACD

I am a Consultant Dermatologist dually trained in Australia and the UK and on the specialist register in both countries (GMC 7110402).  I treat patients of all ages, with all skin problems. My areas of sub-speciality expertise are Connective Tissue Diseases (such as lupus, scleroderma and raynaud’s) and complex medical dermatology (including sarcoidosis, vasculitis and blistering diseases).  I work in London in private rooms on Harley Street; with previous substantive Consultant posts at the Royal Free Hospital London (NHS) and Royal Melbourne Hospital Australia. 
I am passionate about every aspect of my work, and pride myself on going above and beyond to provide personal, compassionate and thorough care for all my patients

ABOUT ME

As a consultant Dermatologist, I am able to provide expert diagnosis and treatment in all areas of general dermatology; such as acne, rosacea, eczema, seborrheic dermatitis, psoriasis, skin cancer and mole checks. I also perform minor procedures and skin surgery.

I have undertaken a sub-specialty fellowship (after my general medical and dermatology specialist training) in connective tissue diseases and complex medical dermatology. My key areas of expertise are therefore lupus, scleroderma, morphoea, raynaud’s, dermatomyositis, overlap CTDs, vasculitis, sarcoidosis and blistering diseases. Accordingly, I worked as a Consultant Dermatologist in the Connective Tissue Disease Service at the Royal Free Hospital (with regular joint clinics with the Rheumatology Scleroderma Unit) for several years, and I am an Honorary Consultant Dermatologist at the Lupus Unit, University College London Hospital.

As well as my clinical work, I am actively involved in research in connective tissue diseases (especially scleroderma and lupus), and am currently completing a PhD investigating the immunopathogenesis of morphoea / scleroderma.  

I also thoroughly enjoy teaching and mentoring junior doctors. I am College Mentor for the Australian Dermatology trainees, and was previously co-Educational lead for Dermatology specialty trainees and Clinical Fellows at the Royal Free Hospital London.  

As an Australian, outside of work, I love living in and exploring London (especially British and Royal family history) and, when possible, visiting other European cities (especially eating in Italy!).  I try to fit in a trip Down Under once a year to stay in touch with family and friends. 

 

MEDICAL TRAINING

Medical Degree

I completed my medical degree in Australia (MBBS, BMedSc), qualifying in 2007 and finishing top of my graduating year; receiving the Sophie Davis Memorial Prize. 

Dermatology Training

After further training as a junior doctor in general medicine, I undertook my Specialist Dermatology training in both Australia (Melbourne) and the UK (London).  During this training I was awarded both the Ken Paver and President’s medals for academic excellence in examinations by the Australasian College of Dermatologists. 

As a Fellow of the Australasian College of Dermatologists (FACD), I was then subsequently recognised by the Royal College of Physicians and General Medical Council (UK), as a Consultant Dermatologist (awarded a Certificate of Entrance to the Specialist Register (CESR)). This means I am now on the Specialist Register in both the UK (GMC) and Australia (AHPRA).  

Sub-specialty Training

Thanks to the award of a Florence Bequest Fellowship and more recently the Paul Eddington Scholarship, I have since completed a clinical and research fellowship in Connective Tissue Diseases and Complex Medical / inflammatory dermatology.

Research

I am currently completing a PhD alongside my clinical work, with the Centre for Rheumatology and Connective Tissue Diseases, University College London. I am investigating the immunology and genetics which underlie scleroderma / morphoea, so that hopefully we can one day develop more precise and targeted treatments for sclerotic skin diseases. My academic work continues to be funded by grants and scholarships, such as the Scientific Research Fund Scholarship.

 

QUALIFICATIONS

MBBS (Hons), 2007

Monash University, AUSTRALIA


BMedSc (Hons), 2007

Monash University, AUSTRALIA


Fellow of the Australasian

College of Dermatologists (FACD), 2014

Australasian College of Dermatologists

Certificate of Entrance to the Specialist Register (CESR), 2015

Royal College of Physicians,

General Medical Council, UK

SPECIALIST REGISTRATION

General Medical Council (UK)

Registration No. 7110402


Australian Health Practitioners

Regulatory Agency

(AUSTRALIA)

Registration No. 1217077

MEMBERSHIPS

Member of the British Association

of Dermatologists

 

Member of the British Society

for Medical Dermatology

 

Fellow of the Australasian

College of Dermatologists


International Fellow of the

American Academy of Dermatologists

Member of the UK Scleroderma Study Group

 

CURRENT AND RECENT POSITIONS

Clinical

  • Consultant Dermatologist     

        25 Harley Street

        London   W1G 9QW

        

        074 4696 6622


  • Honorary Consultant Dermatologist

       University College Hospital London

       Lupus Unit


  • Consultant Dermatologist

       Royal Free Hospital London 

       Department of Dermatology, Connective Tissue Disease Service                                                                                                     

Academic

  • Honorary Clinical Lecturer 

       Centre for Rheumatology and Connective Tissue Diseases

       Scleroderma Unit, Division of Medicine

       University College London Royal Free Campus 

Teaching

  • College Liaison Officer and Trainee Mentor

       Australasian College of Dermatologists

  • Co-Educational Lead Dermatology Trainees and Clinical Fellows

       Royal Free Hospital London

 

RESEARCH AND PUBLICATIONS

Current Research

I am currently completing a PhD investigating the underlying genetic and molecular pathogenesis of morphoea / scleroderma, at the Centre for Rheumatology and Connective Tissue Diseases, University College London.

I am also extensively involved in additional clinically based research, addressing issues such as the impact of connective tissue diseases on patients’ quality of life, and the response of skin lupus to new biologic treatments.

Publications

R Quelhas da Costa, ME Aguirre-Alastuey, DA Isenberg, AM Saracino.  Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus . JAMA Dermatology Oct 31 2018 

Saracino AM, Oakley A.

2017 Morphoea: Dermnet NZ website; https://www.dermnetnz.org/topics/morphoea/

Saracino AM, Denton CP

2017 Systemic Sclerosis: Dermnet NZ website; https://www.dermnetnz.org/topics/systemic-sclerosis
 

H. Bhullar, K. Nicholls, R. Martyres, G. Varigos, J. Douglass, AM. Saracino. Mastocytosis: a case series of 107 consecutive patients. British Journal of Dermatology, 2018; 178(1) 

Saracino AM, Orteu CH. Chapter ‘Morphoea management; current approaches and future perspectives’ in Recent Advances in Dermatology.  In Press 2018 

Saracino AM, Denton CP, Orteu CH. The molecular pathogenesis of morphoea: from genetics to future treatment targets', British Journal of Dermatology. 2017; 177(1): 34-46.

 

Saracino AM, Orteu CH. Severe recalcitrant cutaneous manifestations in systemic lupus erythematosus successfully treatment with fumaric acid esters. British Journal of Dermatology 2017;176(2):472-80

Saracino A, Gordon K, Ffolkes L & Mortimer P. Intralymphatic granulomas in lymphoedema secondary to anogenital granulomatosis. Australasian Journal of Dermatology 2012;54(3):50-61.

Pinder V, Eriyagama S, Saracino A, Wee J. Terra firma-forme dermatosis: another cause of reticulate hyperpigmentation. Clinical & Experimental Dermatology 2012;37(4):446-7

Saracino A, Kelly R, Lieu D, Chong A. Pyoderma gangrenosum requiring inpatient management: A report of 26 cases with follow-up. Australasian Journal of Dermatology 2011;52(3):218-21.

 

Saracino A, Weiland T, Jolly B, Dent AW. Verbal dyspnea score predicts ED departure status. Emergency Medicine Australasia, 2010;22(1):21-9.

 

Saracino A, Weiland T, Dent A, Jolly B. Validation of a verbal dyspnoea rating scale in the emergency department. Emergency Medicine Australasia 2008;20(6):475-81.

 

Saracino A, Weiland T, Dent A, Jolly B. Validation of a verbal rating scale for breathlessness amongst patients referred for cardiac stress tests. Heart, Lung Circulation,2008;17(4):305-312.

 

Saracino A. Review of dyspnoea quantification in the emergency department: Is a rating scale for breathlessness suitable for use as an admission prediction tool? Emergency Medicine Australasia, vol.2007;19(5):394-404.

 

 

Research Abstracts and Presentations

 

A Saracino, M Nino Leon, JW Taanman, C Fonseca, C Orteu, X Shiwen, D Abraham, C Denton, M Ponticos ‘Disease-related site specific metabolic repgramming in linear morphoea fibroblasts’. 5th Systemic Sclerosis World Congress, Bordeaux France, February 2018.

M Nino Leon, X Shi Wen, C Fonseca, C Orteu, D Abraham, C Denton, A Saracino, M Ponticos ‘Cytotoxic T-lymphocyte associated protein-4 expression increased in lesional linear morphoea fibroblasts’. 5th Systemic Sclerosis World Congress, Bordeaux France, February 2018

A Saracino, C George, V Ong, C Fonseca, C Orteu, C Denton ‘Clinical characteristics of 133 adults with linear morphoea; comparing paediatric and adult onset disease’. 5th Systemic Sclerosis World Congress, Bordeaux France, February 2018

A Saracino, A Mizara, V Ong, C Denton ‘Significant impact of skin disease in systemic sclerosis and patient perceived benefits of specialist dermatology input’. 5th Systemic Sclerosis World Congress, Bordeaux France, February 2018.

A Saracino, P Fiandeiro, S Nityanova, V Ong, C Orteu,   C Denton, ‘Panniculitis occurring in systemic sclerosis: a report of 16 cases from a large UK systemic sclerosis cohort’. British Association of Dermatology 2017 Annual Meeting, Liverpool UK, July 2017

 

Leeman H, Saracino AM, Orteu CH, ‘A rare case of PHID syndrome and response to anti-IL6 therapy; an immunopathogenic conundrum’. British Association of Dermatology 2017 Annual Meeting, Liverpool UK, July 2017.

 

Saracino, AM ‘Cutaneous lupus erythematosus; clinical and research update’. Australasian College of Dermatology Annual Scientific Meeting, Sydney Australia, May 2017

 

Saracino, AM ‘Morphoea and systemic sclerosis; role of a dermatologist’. Australasian College of Dermatology Annual Scientific Meeting, Sydney Australia, May 2017.

 

Ramyead S, Saracino AM, Orteu CH ‘Systemic sclerosis and generalised panniculitis’. The Royal Society of Medicine, Dermatology Section, London UK, March 2017.

 

Clayton J, Saracino AM, Orteu CH, ‘Complex overlap connective tissue disease’. The Royal Society of Medicine, Dermatology Section, London UK, March 2017.

 

Leeman H, Saracino AM, Orteu CH, ‘Pigmentary hypertrichosis and insulin dependent diabetes mellitus syndrome’. The Royal Society of Medicine, Dermatology Section, London UK, March 2017.

 

Chinthapalli S, Saracino AM, Orteu CH. ‘Characterising generalised morphoea in adults; disseminated plaque and pansclerotic subtypes’.  American Academy of Dermatology 2017 Annual Meeting, Orlando USA, March 2017

 

Ahmen A, Saracino AM, Orteu CH ‘Significant psychological impact of skin disease in multisystem connective tissue diseases: experience of a tertiary referral centre’ Psychodermatology UK Meeting, British Association of Dermatology, London UK, January 2017.

 

Chinthapalli S, Saracino AM, Orteu CH. ‘Rituximab induces short-term improvement in disseminated discoid lupus erythematosus lesions in the setting of systemic lupus erythematosus associated nephritis’.  12th Medical Dermatology Meeting, Royal College of Physicians / British Association of Dermatology, London UK, January 2017.

 

Leeman H, Saracino AM, Orteu CH ‘Pansclerotic morphoea and eosinophilic fasciitis: a spectrum or distinct entities?’ 12th Medical Dermatology Meeting, Royal College of Physicians / British Association of Dermatology, London UK, January 2017.

 

Flemming C, Saracino AM, Orteu CH, Chan SK ‘Systemic sclerosis or pansclerotic morphoea’ Royal Society of Medicine, Dermatology Section, London UK, November 2016

 

Saracino AM, Orteu CH ‘Rituximab induces short-term improvement in disseminated discoid lupus erythematosus lesions in the setting of systemic lupus erythematosus associated nephritis’ 10th European Lupus Meeting, Venice Italy, October 2016.

 

Bhullar H, Martyres R, Varigos GA, Douglass J, Saracino A 'Mastocytosis: A case series of 107 patients and their treatment responses', Australasian College of Dermatology Annual Scientific Meeting, Perth Australia, May 2016

 

Foeldvari I, Baildam E, Blackley M, Boros C, Fligelstone K, Kienast A, Nemkova D, Pain C, Saracino A, Simonini G, Torok KS, Weibel L, Helmus N ‘Proposal of assessment of the activity of juvenile localised scleroderma: results of the consensus meeting in Hamburg, Germany December 2015’, American College of Rheumatology Annual Meeting, Washington USA, November 2016.

Saracino A, Gordon K, Ffolkes L & Mortimer P  'Intralymphatic granulomas in lymphoedema secondary to anogenital granulomatosis', The Australasian College of Dermatologists 45th Annual Scientific Meeting, Brisbane Australia, May 2012

 

Saracino A, Kelly R, Liew D & Chong A ‘Pyoderma gangrenosum requiring inpatient management: A report of 26 cases with follow-up’, The European Association of Dermatology and Venerology 20th Congress, Lisbon Portugal, October 2011

 

Saracino A, Kelly R, Liew D & Chong A 'Pyoderma gangrenosum requiring inpatient management: A report of 26 cases with follow-up' The Australasian College of Dermatologists 43rd Annual Scientific Meeting, Darwin Australia, May 2010

 

CONTACT

DR AMANDA SARACINO

MEDICAL DERMATOLOGY LONDON

Address:

Private Practice:

     

25 Harley Street,  London  W1G 9QW

   

Email:  

 info@meddermlondon.co.uk

Tel:      074 4696 6622

       

Phone:

074 4696 6622